Articles

Combined genomic and proteomic biomarkers are seemingly the most effective method for predicting progression.

A report on the status of the 5-year-old ongoing MacTel Project, which is slowly answering questions surrounding the disease.

Dr Y. Ralph Chu explains how the ongoing development of increasingly customized IOLs is providing refractive-cataract surgery patients individualized options.

Femtosecond lasers

Dr Mark Wevill discusses the changes occuring in the field of femtosecond lasers and the advantages this technology has enabled.

There are still many challenges facing clinicians in the regeneration of the optic nerve. Dr M. Francesca Cordeiro reveals encouraging research results to help overcome these barriers.

Oertli staff re-vamp

Oertli has welcomed several new employees to their recently improved Marketing and Sales department

LASIK project is underway

A recent LASIK panel symposium has revealed the progresses and plans for the LASIK Quality of Life Collaboration Project.

The presence of cataracts could influence optical coherence tomography (OCT) signal strength (SS) and peripapillary retinal nerve fibre layer (RNFL) thickness measurements

CORNEA_PROTECT®

CORNEA_PROTECT® (2% HPMC) guarantees protection and moisturization of the corneal surface during surgical procedures for up to 20 min. Also applications as a contact agent are possible.

A treatment for dry eye syndrome is to undergo a phase III randomized, placebo-controlled, multicentre study this year following a final licensing agreement with Celtic Therapeutics.

An investigation, published in Inorganic Chemistry, has revealed that the reaction of pirenoxine (PRX) with selenite or calcium ions could be adapted as an anti-cataract agent.